Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Exercise/Conversion of 31,249 DNTH shares, $680.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 31,249 | $680.3K |
| Apr 10, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 8,224 | $147.0K |
| Apr 1, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 74,367 | $627.7K |
| Feb 4, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 150,000 | n/a |
| Dec 6, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 20,000 | $168.8K |
| Sep 26, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 60,000 | n/a |
| Sep 11, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 20,000 | $168.8K |
| Feb 4, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 150,000 | n/a |
| May 29, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 100,000 | n/a |
| Jan 26, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 120,000 | n/a |